Login / Signup

Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease.

Itaru IwamaMasashi YoshidaAyako MiyazawaTomoko HaraRyusuke Nambu
Published in: Inflammatory bowel diseases (2024)
Keyphrases
  • early onset
  • late onset
  • ulcerative colitis
  • disease activity